Reports From the Field

A Service Evaluation of Acute Neurological Patients Managed on Clinically Inappropriate Wards


 

References

Given that the evidence clearly shows that stroke patients are most effectively managed by a multidisciplinary team (MDT) with specialist skills,12 it is likely that other neurological patients, who have similar multifactorial needs, would also benefit. The patients in our evaluation were cared for by nursing staff who lacked specific skills and experience in neurology. The allied health professionals involved were specialists in neurotherapy but were not based on the ward and not directly linked to the ward MDT. A review by Epstein found that the benefits of having a MDT, in any speciality, working together on a ward included improved communication, reduced adverse events, and a reduced length of stay.13 This lack of an effective MDT approach may provide some explanation as to why the average length of stay and the rates of some secondary complications were at such elevated levels.

A systematic review exploring the impact of patients admitted to clinically inappropriate wards in a range of specialities found that these patients were associated with worse outcomes.14 This is supported by our findings, in which a higher rate of pressure ulcers and HAIs were observed when compared to rates in the specialist stroke ward. Again, a potential explanation for this is the impact of patients being managed by clinicians who lack the specialist knowledge of the patient group and the risks they face. Another explanation could be due to the high number of ward moves the patients experienced. Blay et al found that ward moves increased length of stay and carried an associated clinical risk, with the odds of falls and HAIs increasing with each move.15 A case example of this is apparent within our analysis in that the patient who experienced 6 ward moves not only had the longest length of stay (78 days), but also developed a pressure ulcer and 2 HAIs during their admission.

This service evaluation had a number of limitations that should be considered when interpreting the results. First, despite including all patients who met the criteria within the stipulated time frame, the sample size was relatively small, making it difficult to identify consistent patterns of behavior within the data.

Furthermore, caution should be applied when interpreting the comparators used, as the patient groups are not equivalent. The use of comparison against a standard is not a prerequisite in a service evaluation of this nature, but comparators were included to help frame the context for the reader. As such, they should only be used in this way rather than to make any firm conclusions.

Finally, as the evaluation was limited to the use of routinely collected data, there are several variables, other than those reported, which may have influenced the results. For example, it was not possible to ascertain certain demographic details, such as body mass index and socioeconomic factors, nor lifestyle factors such as smoking status, alcohol consumption, and exercise levels, all of which could impact negatively on the outcomes of interest. Furthermore, data were not collected on follow-up services after discharge to evaluate whether these had any impact on readmission rates.

Pages

Recommended Reading

Watch for abnormal movements in hospitalized COVID-19 patients
Journal of Clinical Outcomes Management
Stroke is ‘not a common complication’ in COVID-19
Journal of Clinical Outcomes Management
Infective endocarditis from IV drug use tied to hemorrhagic stroke
Journal of Clinical Outcomes Management
Some MS treatments may heighten COVID risk
Journal of Clinical Outcomes Management
Insomnia? Referral, drugs not usually needed
Journal of Clinical Outcomes Management
High teen BMI linked to stroke risk in young adulthood
Journal of Clinical Outcomes Management
Race, ethnicity, and socioeconomics are often barriers to migraine care
Journal of Clinical Outcomes Management
Healthy lifestyle can reduce dementia risk despite family history
Journal of Clinical Outcomes Management
Large vessel stroke linked to AstraZeneca COVID vaccine
Journal of Clinical Outcomes Management
New AHA/ASA guideline on secondary stroke prevention
Journal of Clinical Outcomes Management